MedTrace Logo

Proparacaine and Mydriatic Eye Drops

NCT01266824 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2013-03-19

Study results available
· View outcomes & findings →

Summary

In this study, we will be evaluating whether premedication with an anesthetic eye drops leads to a decreased sensation of pain when given dilating eye drops prior to eye examinations to evaluate for retinopathy of prematurity in neonatal intensive care unit (NICU) infants.

Conditions

  • Pain
  • Retinopathy of Prematurity

Interventions

DRUG

Proparacaine Hydrochloride Ophthalmic Solution

1 drop into each eye once prior to the first set of mydriatic (dilating) eye drops

Sponsors & Collaborators

Principal Investigators

  • Amy MP Cohen, MD · Children's Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01266824 on ClinicalTrials.gov